MX9605633A - Composicion farmaceutica, metodo y dispositivo para prevenir o tratar resequedad de los ojos o enfermedad ocasionada por la misma. - Google Patents

Composicion farmaceutica, metodo y dispositivo para prevenir o tratar resequedad de los ojos o enfermedad ocasionada por la misma.

Info

Publication number
MX9605633A
MX9605633A MX9605633A MX9605633A MX9605633A MX 9605633 A MX9605633 A MX 9605633A MX 9605633 A MX9605633 A MX 9605633A MX 9605633 A MX9605633 A MX 9605633A MX 9605633 A MX9605633 A MX 9605633A
Authority
MX
Mexico
Prior art keywords
preventing
pharmaceutical composition
disease caused
dry eye
treating dry
Prior art date
Application number
MX9605633A
Other languages
English (en)
Other versions
MXPA96005633A (es
Inventor
Takahiro Ogawa
Noriko Watanabe
Yasushi Okumura
Original Assignee
Tanabe Seiyaku Co
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co, Senju Pharma Co filed Critical Tanabe Seiyaku Co
Publication of MX9605633A publication Critical patent/MX9605633A/es
Publication of MXPA96005633A publication Critical patent/MXPA96005633A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe una composicion farmacéutica para prevenir o tratar resequedad en los ojos o una enfermedad ocasionada por la misma que comprende como un ingrediente activo una cantidad efectiva de ácido sulfodeshidroabiético o una sal farmacéuticamente aceptable del mismo; también se describe un método y dispositivo para prevenir o tratar resequedad en los ojos o una enfermedad ocasionada por la misma.
MXPA/A/1996/005633A 1995-11-15 1996-11-14 Composicion farmaceutica, metodo y dispositivopara prevenir o tratar resequedad de los ojos oenfermedad ocasionada por la misma MXPA96005633A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP322364/1995 1995-11-15
JP7322364A JP3059092B2 (ja) 1995-11-15 1995-11-15 ドライアイおよびドライアイを原因とする疾患の予防・治療剤

Publications (2)

Publication Number Publication Date
MX9605633A true MX9605633A (es) 1998-05-31
MXPA96005633A MXPA96005633A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
CA2190303A1 (en) 1997-05-16
CA2190303C (en) 2007-01-16
DE69602412T2 (de) 1999-11-18
SG42446A1 (en) 1997-08-15
KR970025612A (ko) 1997-06-24
ES2131373T3 (es) 1999-07-16
ATE179888T1 (de) 1999-05-15
TW411275B (en) 2000-11-11
KR100425354B1 (ko) 2004-06-30
DE69602412D1 (de) 1999-06-17
CN1078464C (zh) 2002-01-30
CN1159323A (zh) 1997-09-17
JP3059092B2 (ja) 2000-07-04
JPH09136832A (ja) 1997-05-27
EP0774254A1 (en) 1997-05-21
EP0774254B1 (en) 1999-05-12
US5830913A (en) 1998-11-03

Similar Documents

Publication Publication Date Title
TW376319B (en) Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
AU3990797A (en) Sustained release formulation
CA2123160A1 (en) Controlled release formulation
CA2190303A1 (en) Pharmaceutical composition, method and device for preventing or treating dry eye or disease caused therefrom
AU1399492A (en) Remedies for bone diseases
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
HK1001860A1 (en) I-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
CA2194167A1 (en) Hair-growing agent
ZA968956B (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
CA2154103A1 (en) Treatment of Mucous Membrane Disease, Trauma or Condition and for the Relief of Pain
AU4786396A (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
HUP0100024A3 (en) Pharmaceutical compositions for treating alzheimer's disease containing carvedilol as active ingredient
EP1666041A3 (en) Xanthine derivatives for treating neurodegenerative disorders
GR3025568T3 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia.
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
EP0842663A4 (en) OPHTHALMIC PREPARATIONS
NZ324674A (en) Rapid release tablet comprising tolfenamic acid, alginic acid and a superdisintegrant
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
CA2320627A1 (en) Medicament for treatment of diastolic dysfunction
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal